Although a vast majority of radiologists qualify under the federal government’s meaningful use incentive program for electronic health records, many have lingering concerns about the program, according to a new KLAS and RSNA survey.
Although a vast majority of radiologists qualify under the federal government’s meaningful use incentive program for electronic health records, many have lingering concerns about the program.
In a new survey of 216 radiologists, 40 percent said they had concerns about the lack of clarity of the guidelines or decreased efficiency as a result of adopting the current guidelines. The survey, Radiologists' Take on Meaningful Use: a KLAS-RSNA Report, was conducted by KLAS and RSNA and includes feedback from private practice, hospital-based, and academic radiologists.
Sixty percent of those surveyed said they either plan to or are considering qualifying for meaningful use, but only 6 percent reported that they considered themselves educated on the program.
"These numbers should be a wakeup call for the radiology industry," said Emily Crane, KLAS research director and author of the report. "Getting educated and involved with meaningful use can't wait."
Some radiologists said they were concerned the guidelines don’t take radiology into consideration, and said that clinical decision support would be a beneficial criteria and an important means for ensuring the correct test is ordered. Radiologists also felt that dose tracking and patient engagement were among the least beneficial criteria in the program. In follow-up interviews, radiologists said although patients have a right to their records, there was no apparent medical benefit or necessity for them to have electronic access to their images and reports, according to KLAS.
“We hope that this feedback from radiologists can serve as a guide for the Office of the National Coordinator for HIT and those in Washington who are currently addressing Stage 2 and Stage 3 guidelines. Radiologists would like guidelines that are more appropriate for their practice of radiology," said Crane.
KLAS also asked questions about vendor preparedness to help providers achieve meaningful use. On average, 25 percent of respondents felt their RIS and PACS vendor was not prepared to help them meet the requirements.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC
March 28th 2025Recent research demonstrated a 59 percent reduced risk of progression or death with the radioligand therapy Pluvicto in comparison to a change of androgen receptor pathway inhibitor (ARPI) for patients with metastatic castration-resistant prostate cancer (mCRPC).
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which will be unveiled at the American College of Cardiology (ACC) conference.